Report Categories
View AllRecent Articles
View All
What Is The Volatility Of Pioneer Bancorp Pbfs Stock Price At 14.41 Up 0.14 20260404
Microsoft Flags 190B Capital Spending Need by 2026 Amid Memory Price Surge
US Payrolls Beat Expectations but Report Signals Underlying Economic Weaknesses
VinFast Founders Son Takes Helm as EV Maker Adjusts Global Strategy
Amazon Reports Record Thanksgiving Holiday Sales and Item Volume
Stocks in Focus Anupam Rasayan Bliss GVS Oil India NBCC RVNL Lupin Aurobindo Pharma and CBI May 25 Watchlist
Perpetua Resources Secures 29 Billion US Loan for Critical Minerals Project in Idaho
Teekay Tankers Q1 2026 Earnings Strong EPS Beat Amidst Challenging Tanker Market
EuroDry Ltd Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Move
Paramount Gold Nevada Corp PZG Q1 2026 Earnings Major EPS Miss Stirs Investor Caution
Pathward Financial CASH Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly
Recursion Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Pipeline Progress
Banco Macro BMA Faces Pressure as Shares Slide Over 3
CeriBell CBLL Holds Near Support Amid Modest Gains
GPGI Inc GPGI Rallies 385 Testing Key Resistance Level Near 1304
Equus Total Return Inc EQS Moves Higher as Price Approaches Key Resistance
Masonglory Limited MSGY Holds Steady Near Support as Trading Range Tightens
External Links
LRS Outflows Surge Over 10 in March 2026 as Travel Demand and Investments Drive Capital Abroad
CCU Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Cost Controls
Lithia Motors LAD Gains Nearly 2 as Shares Test Key Resistance Zone
BDX Q1 2026 Earnings EPS Beats Estimates Stock Gains Slightly
USNA Q1 2026 Earnings Strong EPS Surprise Despite Revenue Uncertainty
Digi International Inc DGII Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction
ZBRA Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment Despite Marginal Stock Decline
EFOI Q4 2024 Earnings Narrowing Losses and Positive Stock Reaction Despite Limited Disclosure
Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones
RMTI Q1 2026 Earnings EPS Miss Drags Stock Down 47